INDICATIONS
Rismavac is a live vaccine recommended for the immunisation of healthy day-old chicks against Marek’s Disease and is also indicated where virulent strains of Marek’s Disease are prevalent.
COMPOSITION
Rismavac is a live vaccine containing Marek Disease virus serotype 1, strain CVI-988. Each dose of Rismavac contains at least 3,0 log10 TCID50 serotype 1, strain CVI-988, in the cell associated form, as a suspension of virus containing SPF chicken embryo fibroblasts. The vaccine contains stabilisers and antibiotics.
DIRECTIONS FOR USE – USE ONLY AS DIRECTED
Rismavac should be administered using Nobilis® CA Diluent. The sachet of mixed vaccine should be kept in an ice bath and swirled frequently.
ADMINISTRATION
The vaccine is injected subcutaneously in the neck using an automatic syringe.
Inject 0,2 ml per chick. The entire contents of the sachet must be used within 2 hours of mixing and any remaining vaccine should be discarded according to local waste disposal regulations.
VACCINATION PROGRAMME
Vaccinate chicks in the hatchery.
STORAGE
- The vaccine containing ampoules (which are inserted in metal canes) are stored in liquid nitrogen (-100 °C or below).
- Only 1 ampoule should be removed at any one time.
- The cane holding the remaining ampoules should be replaced immediately in the canister of the liquid nitrogen container.